SPRAVATO®
Spravato, a breakthrough medication, offers renewed hope to individuals battling severe, medication-resistant depression. Approved by the FDA, Spravato represents a significant advancement in the treatment of major depressive disorder (MDD) and depressive symptoms in adults through safe and effective ketamine therapy.
At 180 Mental Health and Wellness, our dedicated team is committed to providing comprehensive care, including Spravato, to support your journey toward improved mental health and well-being.
Conditions Treated by Spravato
Primarily, Spravato has gained FDA approval for the treatment of major depressive disorder (MDD) and severe depressive symptoms in adults unresponsive to other interventions. Beyond depression, ongoing research and clinical trials are exploring its potential effectiveness in managing various mental health disorders.
Currently, Spravato effectively treats:
- Major depressive disorder (MDD)
- Severe depressive symptoms
- Lack of response to other treatments
How Does Spravato Work?
The main active ingredient in Spravato, called esketamine, comes from ketamine. It works by focusing on the brain's NMDA receptors. This is different from regular antidepressants, which usually affect chemicals like serotonin and norepinephrine in the brain.
One of the most remarkable aspects of Spravato is its speed of action. Unlike many traditional antidepressants that may take weeks to alleviate symptoms, Spravato often produces results within hours or days, offering rapid relief from severe depressive symptoms.
No, Spravato is typically used in conjunction with an oral antidepressant. It is administered under medical supervision and is part of a comprehensive treatment plan that may include therapy and other interventions.
Spravato is administered as a nasal spray. Patients receive it in a healthcare provider's office, and they are monitored for a period after each dose.
Yes, common side effects may include dissociation (feeling disconnected from reality), dizziness, nausea, increased blood pressure, and sedation. These effects are typically mild and resolve within hours after administration.
Spravato has a lower potential for addiction and abuse compared to ketamine because it is administered in a controlled medical setting, and patients do not have direct access to the medication.
Spravato is typically prescribed for adults with severe depression that has not responded to other treatments. A healthcare provider will assess an individual's suitability for Spravato based on their specific condition and medical history.
Spravato represents a significant advancement in the treatment of severe depression, offering hope and rapid relief to individuals who have struggled to find effective solutions through conventional therapies. However, its use is closely monitored and should be part of a broader treatment plan overseen by qualified healthcare professionals.
Ketamine Therapy with Spravato Treatment in Phoenix, Arizona
To understand more about Spravato ketamine therapy or to schedule an appointment, please call 180 Mental Health and Wellness at (480) 863-5250 or schedule an appointment online. Our professional staff at 180 Mental Health and Wellness will provide you with information about our services, availability, and any other details you may need for depression treatment in Phoenix, Arizona.
